Immune response of adult people living with human immunodeficiency virus to the introduction of diphtheria and tetanus toxoid (review of literature)

Authors

  • G.O. Revenko State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine”, Dnipro, Ukraine
  • V.V. Mavrutenkov State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine”, Dnipro, Ukraine

DOI:

https://doi.org/10.22141/2312-413x.6.1.2018.125629

Keywords:

HIV-infection, vaccination, immunity, diphtheria, tetanus, review

Abstract

The increase in the number of people living with human immunodeficiency virus (PLHIV) and significant increase in their life expectancy on the background of antiretroviral therapy raises the issue of vaccination of these patients. To prepare the article, we searched for information using Scopus, Web of Science, MedLine, Global Health, Google Scholar, CyberLeninka databases. The analysis of scientific and practical literature shows that PLHIV are often considered to experience a loss of immunological memory of previous immunizations and a less effective immune response, even after the restoration of the immune system when using antiretroviral therapy, which may require additional measures, such as: assessment of the level of specific antibodies, revaccination, or increasing the dose of vaccines. This review emphasizes the importance of vaccination against diphtheria and tetanus as an important preventive strategy among PLHIV in adulthood.

References

Bhatt B, Jindal H, Sk S, Malik JS, Sangwan K, Resident J. Vaccination in HIV positive adults: need to address. Hum Vaccin Immunother. 2014;10(10):3011-2. doi: 10.4161/21645515.2014.971645.

Cioe PA, Melbourne K, Larkin J. An immunization update for HIV-infected adults in the United States: review of the literature. J Assoc Nurses AIDS Care. 2015 Mar-Apr;26(2):201-7. doi: 10.1016/j.jana.2014.11.006.

Setse RW, Siberry GK, Moss WJ, Wheeling J, Bohannon BA, Dominguez KL. Meningococcal Conjugate and Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccination Among HIV-infected Youth. Pediatr Infect Dis J. 2016 May;35(5):e152-7. doi: 10.1097/INF.0000000000001078.

Pinto Neto LFDS, Vieira JV, Ronchi NR. Vaccination coverage in a cohort of HIV-infected patients receiving care at an AIDS outpatient clinic in Espírito Santo, Brazil. Braz J Infect Dis. 2017 Sep-Oct;21(5):515-519. doi: 10.1016/j.bjid.2017.03.021.

WHO-UNICEF estimates of DTP3 coverage. Available from: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragedtp3.html. Assesed: July 15, 2017.

Corre LN, Autran B. Vaccination in HIV-infected Individuals. Future Virology. 2012;7(1):85-102. doi:10.2217/fvl.11.128.

Kerneis S, Launay O, Turbelin C, Batteux F, Hanslik T, Boelle PY. Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis. Clin Infect Dis. 2014 Apr;58(8):1130-9. doi: 10.1093/cid/cit937.

Crum-Cianflone NF, Wallace MR. Vaccination in HIV-Infected Adults. AIDS Patient Care STDS. 2014 Aug 1; 28(8): 397-410. doi: 10.1089/apc.2014.0121.

Ho YL, Enohata T, Lopes MH, De Sousa Dos Santos S. Vaccination in Brazilian HIV-infected adults: a cross-sectional study. AIDS Patient Care STDS. 2008 Jan;22(1):65-70. doi: 10.1089/apc.2007.0059.

Spach DH. Immunizations for HIV-infected adults: indications, timing, and response. Top HIV Med. 2006 Dec-2007 Jan;14(5):154-8. PMID: 17237556.

Crane HM, Dhanireddy S, Kim HN, at al. Optimal timing of routine vaccination in HIV-infected persons. Curr HIV/AIDS Rep. 2009;6(2):93-99. PMID: 19358780.

Grabmeier-Pfistershammer K, Herkner H, Touzeau-Roemer V, Rieger A, Burgmann H, Poeppl W. Low tetanus, diphtheria and acellular pertussis (Tdap) vaccination coverage among HIV infected individuals in Austria. Vaccine. 2015 Jul 31;33(32):3929-32. doi: 10.1016/j.vaccine.2015.06.056.

Moir S., Fauci AS. B-cell exhaustion in HIV infection: the role of immune activation. Current opinion in HIV and AIDS. 2014 Sep;9(5):472-7. doi: 10.1097/COH.0000000000000092.

Crum-Cianflone NF, Sullivan E. Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I. Infect Dis Ther. 2017 Sep;6(3):303-331. doi: 10.1007/s40121-017-0166-x.

Kim DK, Riley LE, Harriman KH, Hunter P, Bridges CB. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older-United States. MMWR Morb Mortal Wkly Rep. 2017 Feb 10;66(5):136-138. doi: 10.15585/mmwr.mm6605e2.

De Milito A. B lymphocytes dysfunction in HIV infection. Current HIV Research. 2004 Jan;2(1):11-21. PMID: 15053337.

Yek C, Gianella S, Plana M, et al. Standard vaccines increase HIV-1 transcription during antiretroviral therapy. AIDS. 2016 Sep 24;30(15):2289-2298. doi:10.1097/QAD.0000000000001201.

World Health Organization. Vaccine position papers. Available from: http://www.who.int/immunization/documents/positionpapers/en/. Accessed: Mar 30, 2017.

Centers for Disease Control and Prevention, National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. Available from: https://aidsinfo.nih.gov/guidelines/html/4/adult-and-adolescent-opportunistic-infection/318/introduction. Accessed: Mar 30, 2017.

Quinn KJ, McCarty EJ, Quah SP, Emerson CR, Donnelly CM. Managing vaccines: defining the remit of primary care and specialist HIV clinics in the delivery of immunization to individuals with HIV infection. Int J STD AIDS. 2012 Feb;23(2):136-7. doi: 10.1258/ijsa.2011.011231.

BHIVA. Guidelines on the use of vaccines in HIV-positive adults 2015. Available from: http://www.bhiva.org/vaccination-guidelines.aspx. Accessed: 30 Mar 2017.

European AIDS Clinical Society (EACS). Guidelines for the treatment of HIV, Version 8,2, January 2017. Available from: http://www.eacsociety.org/files/guidelines_8.2-english.pdf. Accessed: Mar 30, 2017.

Frésard A, Gagneux-Brunon A, Lucht F, Botelho-Nevers E, Launay O. Immunization of HIV-infected adult patients - French recommendations. Hum Vaccin Immunother. 2016 Nov;12(11):2729-2741. doi: 10.1080/21645515.2016.1207013.

Ministry of Health of Ukraine. Order № 551 dated August 11, 2014: On the improvement of preventive vaccination in Ukranian. Available from: http://zakon3.rada.gov.ua/laws/show/z1237-14. (in Ukranian).

Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014 Feb;58(3):e44-100. doi: 10.1093/cid/cit684.

Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jan;58(1):e1-34. doi: 10.1093/cid/cit665.

Simonsen SE, Kepka D, Thompson J, Warner EL, Snyder M, Ries KM. Preventive health care among HIV positive women in a Utah HIV/AIDS clinic: a retrospective cohort study. BMC Womens Health. 2014 Mar 4;14(1):37. doi: 10.1186/1472-6874-14-37.

Kurtzhals JA, Kjeldsen K, Heron I, Skinhоj P. Immunity against diphtheria and tetanus in human immunodeficiency virus-infected Danish men born 1950-59. APMIS. 1992;100(9):803-8. PMID: 1356366.

Kroon FP, van Dissel JT, Labadie J, van Loon AM, van Furth R. Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis. 1995 Nov;21(5):1197-203. PMID: 8589143.

Talesnik E, Vial PA, Labarca J, Mendez C, Soza X. Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):471-7. PMID: 9859960.

Bonetti TC, Succi RC, Weckx LY, Tavares-Lopes L, de Moraes-Pinto MI. Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women. Vaccine. 2004 Sep 9;22(27-28):3707-12. doi: 10.1016/j.vaccine.2004.03.023.

Alagappan K, McGowan J, DeClaro D, Ng D, Silverman RA. Tetanus antibody protection among HIV-infected US-born patients and immigrants. Int J Emerg Med. 2008 Jun;1(2):123-6. doi: 10.1007/s12245-008-0020-8.

Burton CT, Goodall RL, Samri A, еt al. Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy. Clin Exp Immunol. 2008;152(2):252-257, doi: 10.1111/j.1365-2249.2008.03611.x.

Salawu L, Ndakotsu MA. Tetanus antibody in Nigerians living with HIV/AIDS: A preliminary report. Malays J Microbiol. 2010;6(2):111-114. doi: 10.21161/mjm.10708.

Andrade RM, Andrade AF, Lazaro MA, еt al. Failure of highly active antiretroviral therapy in reconstituting immune response to Clostridium tetani vaccine in aged AIDS patients. J Acquir Immune Defic Syndr. 2010;54:10-7. doi: 10.1097/QAI.0b013e3181d6003b.

Eslamifar A, Ramezani A, Banifazl M, Aghakhani A. Tetanus and diphtheria seroprevalence in patients infected with human immunodeficiency virus. Iranian Journal of Pathology. 2012;7(1):27-31.

Speranza FA, Ishii SK, Thuler LC, еt al. Diphtheria Antibodies and T lymphocyte Counts in Patients Infected With HIV-1. Braz J Microbiol. 2012 Jul;43(3):946-50. doi: 10.1590/S1517-838220120003000014.

Mullaert J, Abgrall S, Lele N, еt al. Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study. Vaccine. 2015 Sep 11;33(38):4938-44. doi: 10.1016/j.vaccine.2015.07.036.

Sticchi L, Bruzzone B, Caligiuri P, еt al. Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients. Hum Vaccin Immunother. 2015;11(1):263-9. doi: 10.4161/hv.36162.

Downloads

Issue

Vol. 6 No. 1 (2018)

Section

Review

License

Copyright (c) 2018 ACTUAL INFECTOLOGY

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our edition uses the copyright terms of Creative Commons for open access journals.

Authors, who are published in this journal, agree with the following terms:

  1. The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
  2. Directing  the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
  3. The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
  4. The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
  5. The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
  6. The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
  7. The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.